Watt HC - Search Results

1

A volumetric magnetic resonance imaging study of the amygdala in frontotemporal lobar degeneration and Alzheimer's disease.

Whitwell JL, Sampson EL, Watt HC, Harvey RJ, Rossor MN, Fox NC. Whitwell JL, et al. Among authors: watt hc. Dement Geriatr Cogn Disord. 2005;20(4):238-44. doi: 10.1159/000087343. Epub 2005 Aug 5. Dement Geriatr Cogn Disord. 2005. PMID: 16088140 Free article.

2

Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging.

Whitwell JL, Crum WR, Watt HC, Fox NC. Whitwell JL, et al. Among authors: watt hc. AJNR Am J Neuroradiol. 2001 Sep;22(8):1483-9. AJNR Am J Neuroradiol. 2001. PMID: 11559495 Free PMC article.

3

Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease.

Petzold A, Jenkins R, Watt HC, Green AJ, Thompson EJ, Keir G, Fox NC, Rossor MN. Petzold A, et al. Among authors: watt hc. Neurosci Lett. 2003 Jan 23;336(3):167-70. doi: 10.1016/s0304-3940(02)01257-0. Neurosci Lett. 2003. PMID: 12505619

4

Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study.

Chan D, Janssen JC, Whitwell JL, Watt HC, Jenkins R, Frost C, Rossor MN, Fox NC. Chan D, et al. Among authors: watt hc. Lancet. 2003 Oct 4;362(9390):1121-2. doi: 10.1016/S0140-6736(03)14469-8. Lancet. 2003. PMID: 14550701

5

The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort.

Godbolt AK, Cipolotti L, Watt H, Fox NC, Janssen JC, Rossor MN. Godbolt AK, et al. Arch Neurol. 2004 Nov;61(11):1743-8. doi: 10.1001/archneur.61.11.1743. Arch Neurol. 2004. PMID: 15534185

6

Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation.

Rees J, Watt H, Jäger HR, Benton C, Tozer D, Tofts P, Waldman A. Rees J, et al. Eur J Radiol. 2009 Oct;72(1):54-64. doi: 10.1016/j.ejrad.2008.06.013. Epub 2008 Jul 15. Eur J Radiol. 2009. PMID: 18632238

7

Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI.

Werring DJ, Frazer DW, Coward LJ, Losseff NA, Watt H, Cipolotti L, Brown MM, Jäger HR. Werring DJ, et al. Brain. 2004 Oct;127(Pt 10):2265-75. doi: 10.1093/brain/awh253. Epub 2004 Jul 28. Brain. 2004. PMID: 15282216

8

The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.

Dehmeshki J, Chard DT, Leary SM, Watt HC, Silver NC, Tofts PS, Thompson AJ, Miller DH. Dehmeshki J, et al. Among authors: watt hc. J Neurol. 2003 Jan;250(1):67-74. doi: 10.1007/s00415-003-0955-x. J Neurol. 2003. PMID: 12527995

9

Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease.

Khan NL, Katzenschlager R, Watt H, Bhatia KP, Wood NW, Quinn N, Lees AJ. Khan NL, et al. Neurology. 2004 Apr 13;62(7):1224-6. doi: 10.1212/01.wnl.0000118281.66802.81. Neurology. 2004. PMID: 15079034 Free article.

10

Olfactory function distinguishes vascular parkinsonism from Parkinson's disease.

Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Katzenschlager R, et al. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1749-52. doi: 10.1136/jnnp.2003.035287. J Neurol Neurosurg Psychiatry. 2004. PMID: 15548497 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters